Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Dubbink

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Pathology, Research and Practice|August 13, 2019
Granular dot-like staining with MLH1 immunohistochemistry is a clone-dependent artefactS Dasgupta, P C Ewing-Graham, F H Groenendijk, et al.
Expert Review of Respiratory Medicine|November 22, 2023
Recommendations on scuba diving in Birt-Hogg-Dubé syndromeL van Riel, R A van Hulst, L van Hest, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2019
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancerM A Pruis, W R R Geurts-Giele, Thüsen J H von der, et al.
Clinical Genetics|February 5, 2011
PTEN in colorectal cancer: a report on two Cowden syndrome patientsR Kersseboom, H J Dubbink, W E Corver, et al.
Clinical Genetics|January 6, 2011
Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutationsC H M Leenen, W R R Geurts-Giele, H J Dubbink, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|October 24, 2009
Functional analysis of novel androgen receptor mutations in a unique cohort of Indonesian patients with a disorder of sex developmentP Elfferich, A Z Juniarto, H J Dubbink, et al.
Familial Cancer|September 22, 2017
Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriersA Goverde, M C W Spaander, D Nieboer, et al.
Neurology|November 26, 2009
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomideH J Dubbink, W Taal, R van Marion, et al.
Neuro-Oncology|November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung CancerTeodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pathology, Research and Practice|August 13, 2019
Granular dot-like staining with MLH1 immunohistochemistry is a clone-dependent artefactS Dasgupta, P C Ewing-Graham, F H Groenendijk, et al.
Expert Review of Respiratory Medicine|November 22, 2023
Recommendations on scuba diving in Birt-Hogg-Dubé syndromeL van Riel, R A van Hulst, L van Hest, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2019
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancerM A Pruis, W R R Geurts-Giele, Thüsen J H von der, et al.
Clinical Genetics|February 5, 2011
PTEN in colorectal cancer: a report on two Cowden syndrome patientsR Kersseboom, H J Dubbink, W E Corver, et al.
Clinical Genetics|January 6, 2011
Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutationsC H M Leenen, W R R Geurts-Giele, H J Dubbink, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|October 24, 2009
Functional analysis of novel androgen receptor mutations in a unique cohort of Indonesian patients with a disorder of sex developmentP Elfferich, A Z Juniarto, H J Dubbink, et al.
Familial Cancer|September 22, 2017
Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriersA Goverde, M C W Spaander, D Nieboer, et al.
Neurology|November 26, 2009
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomideH J Dubbink, W Taal, R van Marion, et al.
Neuro-Oncology|November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung CancerTeodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
Pageof 3